TASER/Mossberg to Produce Dedicated Less-Lethal Shotgun

New Radial Ammunition Key Technology to Prevent Firing of Lethal Rounds


SCOTTSDALE, Ariz., Feb. 1, 2008 (PRIME NEWSWIRE) -- TASER International, Inc. (Nasdaq:TASR), a market leader in advanced electronic control devices, today announced it will debut the new TASER X12 LLS Mossberg(r) shotgun during the 2008 SHOT Show in Las Vegas to be held February 2-5, 2008. The TASER X12 Less Lethal Shotgun (LLS) is a fully integrated less-lethal platform manufactured by Mossberg that has been optimized for the TASER eXtended Range Electronic Projectile (XREP), while providing for integration of the TASER(r) X26 electronic control device (ECD) for close-in engagements. The TASER X12 LLS includes TASER Radial Ammunition Key technology (patent pending) to prevent the system from accepting lethal 12-gauge rounds in order to remove the possibility of end users loading a lethal round in a less-lethal system during high stress situations.

TASER International will be in booth number 22117 in the Gold Hall outside of the Las Vegas Convention Center this weekend. Mossberg will be in booth number 4751 in the central exhibit halls (C1-C5.1).

"In speaking with our customers and law enforcement experts, we found that many law enforcement agencies would prefer dedicated 12-gauge systems for less-lethal use only," commented Rick Smith, Chief Executive Officer of TASER International, Inc. "However, none of the systems on the market today actually prevent the operator from inadvertently loading a deadly round of buckshot or slugs. The TASER X12 LLS is designed with the important safeguard of precluding the possibility of lethal accidents through round mis-identification."

The TASER X12 LLS provides a dedicated less-lethal platform based on the proven Mossberg 500 shotgun which is the only 12-gauge system to attain Mil-Spec certification.

In addition to the TASER Radial Ammunition Key system, the TASER X12 LLS also provides the following features:



 * A high twist, rifled barrel system that is optimized for the lower
   velocities of less-lethal projectiles.  Whereas standard Mossberg
   rifled barrels have a twist of 1 in 36 inches, the twist ratio for
   the TASER X12 LLS is 1 in 18 inches  This higher twist rate provides
   enhanced projectile stability at the lower velocities used for
   less-lethal projectiles such as the TASER XREP projectile.
 * A Picatinny Rail system with the X-Rail mount pre-installed.  The
   X-Rail mount allows the user to mount a standard TASER X26 ECD to
   the system.  Together, the TASER X12 LLS with TASER X26 ECD
   integration gives the operator the ability to engage subjects across
   the full range of engagement distances, with the TASER X26 ECD
   optimized for engagements within 20 feet, and the TASER XREP
   projectile for subjects beyond 20 feet.
 * TASER-Yellow coloration of the stock and fore-end of the shotgun for
   immediate identification as a less-lethal system
 * A ghost ring sighting system
 * Collapsible tactical stock

"We are very excited to be partnering with TASER International on the manufacturing and development for the TASER X12 LLS system," said A. Iver Mossberg, Jr., CEO for Mossberg. "Teaming Mossberg's vast array of product knowledge and experience with TASER International's pioneering less-lethal technology will only enhance our continuation as the market leaders in firearms innovation."

TASER International will begin training the agencies involved in the pilot programs in February and will release the TASER XREP into pilot programs by the end of the first quarter. The TASER XREP is a wireless Neuro Muscular Incapacitation projectile designed for a 12-gauge platform. The XREP which contains miniaturized TASER technology as well as groundbreaking flight stabilization and microprocessor-controlled intelligent electrode selection technologies, weighs only 14 grams, or half an ounce, and has a maximum range of 65 feet or 20 meters.

TASER expects to complete pilot programs and release the TASER XREP product and the TASER X12 by the end of 2008, pending results of the pilot programs.

Photos and video of the TASER XREP and TASER X12 are posted at www.TASER.com/XREP.

About TASER International, Inc.

TASER International's products protect life. TASER provides advanced Electronic Control Devices (ECDs) for use in the law enforcement, medical, military, corrections, professional security, and personal protection markets. TASER devices use proprietary technology to incapacitate dangerous, combative, or high-risk subjects who pose a risk to law enforcement officers, innocent citizens, or themselves in a manner that is generally recognized as a safer alternative to other uses of force. For more information please call TASER International at (800) 978-2737 or visit our website at www.TASER.com.

The TASER International logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=2931

About O.F. Mossberg & Sons, Inc.

Founded in 1919, O.F. Mossberg & Sons, Inc. is the oldest family-owned firearms manufacturer in America, and is the largest pump-action shotgun manufacturer in the world. Leading the way with over 100 design and utility patents to its credit, and standing as the first ISO 9001 Certified long-gun manufacturer, Mossberg is considered to be one of the most innovative firearms manufacturers in U.S. History. For more information please call O.F. Mossberg & Sons, Inc. at (800) 363-3555 or visit our website at www.Mossberg.com.

Note to Investors

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements, without limitation, regarding our expectations, beliefs, intentions or strategies regarding the future. We intend that such forward-looking statements be subject to the safe-harbor provided by the Private Securities Litigation Reform Act of 1995. The forward-looking information is based upon current information and expectations regarding TASER International. These estimates and statements speak only as of the date on which they are made, are not guarantees of future performance, and involve certain risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results could materially differ from what is expressed, implied, or forecasted in such forward-looking statements.

TASER International assumes no obligation to update the information contained in this press release. These statements are qualified by important factors that could cause our actual results to differ materially from those reflected by the forward-looking statements. Such factors include but are not limited to: (1) market acceptance of our products; (2) our ability to establish and expand direct and indirect distribution channels; (3) our ability to attract and retain the endorsement of key opinion-leaders in the law enforcement community; (4) the level of product technology and price competition for our products; (5) the degree and rate of growth of the markets in which we compete and the accompanying demand for our products; (6) risks associated with rapid technological change and new product introductions; (7) competition; (8) litigation including lawsuits resulting from alleged product related injuries and death; (9) media publicity concerning allegations of deaths and injuries occurring after use of the TASER device and the negative effect this publicity could have on our sales; (10) TASER device tests and reports; (11) product quality; (12) implementation of manufacturing automation; (13) potential fluctuations in our quarterly operating results; (14) financial and budgetary constraints of prospects and customers; (15) order delays; (16) dependence upon sole and limited source suppliers; (17) negative reports concerning the TASER device; (18) fluctuations in component pricing; (19) government regulations and inquiries; (20) dependence upon key employees and our ability to retain employees; (21) execution and implementation risks of new technology; (22) ramping manufacturing production to meet demand; (23) medical and safety studies; (24) field test results; and (25) other factors detailed in our filings with the Securities and Exchange Commission, including, without limitation, those factors detailed in the Company's Annual Report on Form 10-K and its Form 10-Qs.

The statements made herein are independent statements of TASER International. The inclusion of any third parties does not represent an endorsement of any TASER International products or services by any such third parties.



            

Contact Data